1-[5-chloro-6-(trifluoromethoxy)-1H-1,3-benzodiazol-2-yl]-1H-pyrazole-4-carboxylic acid, 5mg

3-Amino-1-methylcyclobutan-1-ol, 97%, 250mg

5-Chloro-3-(trifluoromethyl)pyridin-2-ol, 95.0%, 5g

1-(2-Methoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 5g

1-(3-methyl-2-pyridinyl)ethanamine, 95.0%, 1g

2-Hydroxyisobutyric acid, 95.0%, 1kg

tert-Butyl (2S,4R)-4-((tert-butyldimethylsilyl)oxy)-2-formylpyrrolidine-1-carboxylate, 98%, 5g

2-(2-Methoxyphenoxy)-1-phenylethanol, 97%, 1g

3',3'-Difluoro-1,4'-bipiperidine dihydrochloride, 97%, 250mg

2-methyl-2,9-diazaspiro[5.5]undecane dihydrochloride, 95.0%, 1g

n-Nonane, 99%, for synthesis, 500 ml, glass packaging

Ethylhydrazine oxalate, 95.0%, 100g

1,3-Diaminopentane>96.0%(GC)500mL